SelectQuote, Inc.
- Open
- 0.51
- Day high
- 0.56
- Day low
- 0.49
- Prev close
- 0.52
- Volume
- 3.1M
- Mkt cap
- $99M
- P/E (TTM)
- —
- EPS (TTM)
- —
- P/B
- 0.2
- P/S
- 0.1
- Yield
- —
- Per share
- —
SelectQuote, Inc. (SLQT) is a Financial Services company listed on NYSE. The stock is down 77% over the past year. Drillr has 2 published research articles covering SLQT.
SelectQuote, Inc. (SLQT) financials & analyst ratings
Fundamentals (TTM)
Source: exchange market data + company filings. Figures are trailing-twelve-month or as most recently reported. For informational purposes only — not investment advice.
SLQT earnings date, history & EPS estimates
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Aug 25, 2026 | $-0.17 | $-0.19 | -15.2% | $322M | -9.0% |
| May 5, 2026 | $-0.02 | $0.15 | +850.0% | $431M | -1.8% |
| Feb 5, 2026 | $0.17 | $0.26 | +52.9% | $537M | +22.4% |
| Nov 6, 2025 | $-0.32 | $-0.26 | +18.8% | $329M | +1.6% |
| Aug 21, 2025 | $-0.18 | $-0.17 | +5.6% | $345M | +3.3% |
| Sep 13, 2024 | $-0.15 | $-0.18 | -20.0% | $307M | +12.6% |
| May 9, 2024 | $0.03 | $0.05 | +66.7% | $376M | +37.9% |
| Feb 7, 2024 | $0.11 | $0.11 | +0.0% | $405M | +36.3% |
| Nov 2, 2023 | $-0.27 | $-0.19 | +29.6% | $233M | +14.4% |
| Sep 13, 2023 | $-0.29 | $-0.23 | +20.7% | $222M | +22.3% |
| Feb 7, 2023 | $0.03 | $0.14 | +356.5% | $319M | +6.3% |
| Nov 3, 2022 | $-0.20 | $-0.26 | -30.0% | $162M | +12.2% |
SLQT insider trading activity (SEC Form 4)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 4, 2026 | Grant William Thomas IIIofficer: CHIEF OPERATING OFFICER | Option | 133,333 | — |
| Aug 4, 2026 | Matthews Joshua Brandonofficer: President, SelectQuote Senior | Grant | 175,000 | — |
| Aug 4, 2026 | Boulware Daniel Allenofficer: GENERAL COUNSEL AND SECRETARY | Option | 88,889 | — |
| Aug 4, 2026 | Grant Robert Clayofficer: PRESIDENT | Grant | 575,000 | — |
| Aug 4, 2026 | Danker Timothy Robertdirector, officer: CHIEF EXECUTIVE OFFICER | Option | 266,668 | — |
| Aug 4, 2026 | Fisher Stephanie D.officer: Chief Accounting Officer | Option | 24,788 | — |
| Aug 4, 2026 | Clement Ryan Mooreofficer: Chief Financial Officer | Option | 90,000 | — |
| Aug 4, 2026 | Clement Ryan Mooreofficer: Chief Financial Officer | Option | 63,897 | — |
| Aug 4, 2026 | Boulware Daniel Allenofficer: GENERAL COUNSEL AND SECRETARY | Option | 15,087 | — |
| Aug 4, 2026 | Boulware Daniel Allenofficer: GENERAL COUNSEL AND SECRETARY | Tax | 91,909 | $0.75 |
| Aug 4, 2026 | Anderson Sarah Taylorofficer: (See Remarks) | Option | 3,196 | — |
| Aug 4, 2026 | Anderson Sarah Taylorofficer: (See Remarks) | Option | 4,854 | — |
| Aug 4, 2026 | Boulware Daniel Allenofficer: GENERAL COUNSEL AND SECRETARY | Option | 45,261 | — |
| Aug 4, 2026 | Grant Robert Clayofficer: PRESIDENT | Option | 122,470 | — |
| Aug 4, 2026 | Fisher Stephanie D.officer: Chief Accounting Officer | Option | 9,518 | — |
Source: SLQT SEC Form 4 filings, latest Aug 4, 2026. For informational purposes only — not investment advice.
See the full SLQT insider & 13F page →SLQT research & analysis
Hays (HAYPY), SelectQuote (SLQT): AI Absorbs the Matching Work
Hays cut permanent placement volumes 14% as average fees rose 2%; SelectQuote ties over $30m of annual savings to AI and keeps licensed agents on the call.
6098.TBEKEFAAegon (AEG) and Ethos (LIFE) issue life policies with no medical exam
US life carriers now underwrite from prescription and medical-claims data: Aegon says a decision takes under 12 minutes and new life sales rose 54% in H1 2026.
AEGCNODGX
SelectQuote, Inc. company profile
Overview
SelectQuote, Inc. (NYSE:SLQT) is a technology-enabled insurance distribution company founded in 1985 and headquartered in Overland Park, Kansas. The company went public in May 2020 and operates as a direct-to-consumer platform that connects consumers with various insurance carriers across the United States. SelectQuote has evolved from a traditional insurance broker into a comprehensive healthcare services provider, particularly focused on serving the senior population through its Medicare-related products and expanding into adjacent healthcare services through its SelectRx pharmacy division.
Business
SelectQuote operates in the insurance brokerage industry, functioning as an intermediary between consumers and insurance carriers. The company does not underwrite insurance policies itself but rather acts as a distribution channel that helps consumers find and purchase appropriate insurance coverage from third-party carriers. The company operates through three primary business segments: 1. Senior Segment (approximately 40-50% of revenue): This is SelectQuote's core business, focusing on Medicare-related insurance products for Americans aged 65 and older. The segment distributes Medicare Advantage plans (comprehensive health insurance that replaces traditional Medicare), Medicare Supplement insurance (also called Medigap, which covers gaps in traditional Medicare), Medicare Part D prescription drug plans, and other ancillary senior health products including dental, vision, and hearing coverage. Medicare Advantage represents the largest portion of this segment's revenue. 2. Healthcare Services/SelectRx (approximately 35-45% of revenue): This rapidly growing segment operates SelectRx, a direct-to-consumer pharmacy service that delivers prescription medications directly to customers' homes. SelectRx primarily serves Medicare beneficiaries and focuses on medication adherence, convenience, and cost savings. The service includes medication synchronization, automatic refills, and clinical support services. This segment has experienced explosive growth, with membership increasing from around 25,000 to over 100,000 members in recent years. 3. Life Insurance (approximately 10-15% of revenue): This segment distributes term life insurance policies to consumers, primarily through the company's call center operations and agent network. The company previously operated an Auto & Home segment but has largely rationalized this business and it no longer represents a material portion of revenue. SelectQuote's distribution model relies heavily on inbound call centers staffed by licensed insurance agents who receive leads generated through various marketing channels including television advertising, digital marketing, and referrals. The company has invested significantly in technology to improve lead routing, agent productivity, and customer matching with appropriate insurance products.
Revenue model
SelectQuote generates revenue primarily through commissions paid by insurance carriers when customers purchase policies through their platform. The company does not charge consumers directly for its services; instead, insurance carriers pay SelectQuote commissions for successfully placing policies. The commission structure varies by product type and carrier relationship. For Medicare Advantage plans, SelectQuote typically receives an upfront commission when a policy is sold, followed by ongoing renewal commissions for as long as the customer maintains the policy. These commissions are often structured with higher payments in the first year and lower ongoing payments in subsequent years. Life insurance commissions follow a similar structure with upfront and renewal components. For SelectRx, the revenue model is different as it operates as a direct-pay pharmacy service. Customers pay SelectQuote directly for prescription medications, and the company generates revenue through the markup on pharmaceutical products and dispensing fees. SelectRx also benefits from improved medication adherence, which can generate additional revenue through insurance carrier partnerships focused on health outcomes. The company's paying customers are primarily individual consumers, particularly seniors aged 65 and older for the Medicare-related products, and working-age adults for life insurance. However, the ultimate revenue source is the insurance carriers who pay commissions for successful policy placements. Several factors can significantly impact SelectQuote's margins and profitability. Regulatory changes in Medicare reimbursement rates directly affect carrier profitability and their willingness to pay high commissions to distributors. When Medicare Advantage reimbursement rates are cut, carriers typically reduce benefits or commission payments to brokers. Market competition among insurance brokers can pressure commission rates downward, while competition among carriers can drive commission rates higher. Agent productivity and retention significantly impact margins, as experienced agents typically have higher close rates and can handle more complex cases efficiently. Marketing costs and lead quality directly affect customer acquisition costs, with television advertising costs and digital marketing expenses representing major variable costs. Regulatory compliance costs in the heavily regulated insurance industry can impact margins, particularly when new regulations require additional training, systems, or processes.
Competitive moat
SelectQuote's competitive moat is moderate but faces ongoing challenges in an increasingly competitive insurance distribution landscape. The company's primary advantages stem from its scale and operational efficiency in Medicare-related insurance distribution, particularly its ability to maintain relationships with multiple insurance carriers and efficiently match consumers with appropriate products. The company's strongest moat elements include its established carrier relationships and regulatory expertise. Maintaining relationships with major insurance carriers requires significant scale, compliance infrastructure, and proven performance metrics. SelectQuote's track record of delivering quality customers to carriers provides some protection against new entrants. The company's technology platform and data analytics capabilities for lead routing, agent productivity optimization, and customer matching create operational advantages that are difficult for smaller competitors to replicate. However, SelectQuote's moat faces significant vulnerabilities. The insurance brokerage industry has relatively low barriers to entry for basic operations, and the company faces intense competition from both traditional brokers and newer digital-first platforms. Regulatory dependency represents a major weakness, as changes in Medicare reimbursement rates or commission structures can dramatically impact profitability regardless of operational efficiency. The company has limited pricing power since it cannot directly control the insurance products it sells or the commissions it receives. Potential disruption comes from several sources: direct-to-consumer efforts by insurance carriers themselves, which could eliminate the need for brokers; technology-enabled competitors offering more streamlined digital experiences; and regulatory changes that could limit broker compensation or require different distribution models. The SelectRx pharmacy business offers some diversification and potential for a stronger moat through direct customer relationships and recurring revenue, but this segment is still developing and faces competition from established pharmacy chains and mail-order services. Overall, SelectQuote operates in a competitive industry with moderate switching costs for consumers and limited differentiation opportunities, making its long-term moat sustainability questionable without continued operational improvements and successful diversification into adjacent healthcare services.
Risks & safety
SelectQuote presents moderate financial risk with improving but still concerning leverage and liquidity metrics. Liquidity and Debt: • Cash position: $85 million as of Q3 2025, improved from $12 million in Q2 2025 following capital raising • Total debt-to-equity ratio: 0.17 (significantly improved from over 2.0 in prior periods) • Completed $350 million preferred equity offering and $100 million securitization, substantially improving capital structure • Current ratio: 1.86, indicating adequate short-term liquidity • Free cash flow: $70 million in Q3 2025, demonstrating improved cash generation Valuation Metrics: • Price-to-earnings ratio: 7.0 (based on recent profitable quarters) • EV/EBITDA: 6.2, relatively attractive for a growing services business • Price-to-book ratio: 1.6, reasonable given asset-light business model • Trading near 52-week lows despite operational improvements Other Considerations: • Regulatory investigation by DOJ creates uncertainty and potential legal costs • Commission receivables of $1 billion represent significant working capital but also collection risk • Seasonal business model with concentrated Medicare enrollment periods creates cash flow volatility • Dependence on Medicare reimbursement rates and carrier commission structures creates external risk factors beyond management control
Recent development
Over the past few years, SelectQuote has undergone a significant strategic transformation focused on improving profitability and diversifying beyond traditional insurance brokerage. The company shifted from a pure growth strategy to emphasizing unit economics and cash flow generation, particularly after experiencing significant losses in fiscal 2022. A key strategic pivot has been the dramatic expansion of SelectRx, the company's direct-to-consumer pharmacy service. This business has grown from minimal revenue to nearly $200 million quarterly revenue, with membership expanding from around 25,000 to over 100,000 members. SelectRx represents SelectQuote's effort to create recurring revenue streams and deeper customer relationships beyond one-time insurance commissions. The company has also focused heavily on operational efficiency improvements in its core Medicare Advantage business. Management reduced agent headcount while maintaining or increasing policy production through better agent training, improved lead routing technology, and focusing on higher-quality leads. The mix of experienced agents increased from 20% to 70%, resulting in significantly higher close rates and reduced customer acquisition costs. Capital structure improvements have been a major focus, with SelectQuote completing a $350 million preferred equity offering and a $100 million securitization of Medicare Advantage commission receivables. These transactions extended debt maturities, reduced interest costs, and provided operational flexibility for growth investments. The company has also invested in technology and automation, implementing AI tools for call screening and process optimization, and opening a new distribution facility in Kansas for SelectRx operations. Additionally, SelectQuote has rationalized underperforming segments, largely exiting the Auto & Home insurance business to focus resources on higher-margin opportunities. Recent developments include dealing with a DOJ investigation related to business practices, which management has stated they are fully cooperating with while firmly rejecting the allegations. The company has also navigated challenging Medicare Advantage market conditions caused by reduced carrier reimbursement rates, adapting by focusing on efficiency rather than pure growth.
SLQT company profile · for informational purposes only — not investment advice.
Track SLQT with Drillr
SEC filings, earnings calls, insider activity, alt-data signals — all queryable through Drillr's AI terminal and MCP API.
Try Drillr for free